Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.
Olanzapine is the one of first line antipsychotic drug for schizophrenia and other serious mental illness. However, it is associated with troublesome metabolic side-effects, particularly body weight gain and obesity. The antagonistic affinity to histamine H1 receptors (H1R) of antipsychotic drugs ha...
| 出版年: | PLoS ONE |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Public Library of Science (PLoS)
2014-01-01
|
| オンライン･アクセス: | http://europepmc.org/articles/PMC4118967?pdf=render |